{"id":630556,"date":"2024-11-21T11:39:05","date_gmt":"2024-11-21T16:39:05","guid":{"rendered":"https:\/\/www.singlecare.com\/blog\/?p=630556"},"modified":"2026-01-28T13:59:26","modified_gmt":"2026-01-28T18:59:26","slug":"novolog-flexpen-alternatives","status":"publish","type":"post","link":"https:\/\/www.singlecare.com\/blog\/novolog-flexpen-alternatives\/","title":{"rendered":"Novolog FlexPen alternatives"},"content":{"rendered":"

NovoLog Flexpens are a multi-dose injectable device containing insulin aspart manufactured by Novo Nordisk. Insulin aspart is a rapid-acting insulin analog that is derived from a modification to regular insulin. NovoLog Flexpens are indicated for glycemic control in both Type 1 diabetes mellitus and Type 2 diabetes mellitus. It is estimated that over 34 million Americans have a form of diabetes, so the need for effective drug therapies is widespread. Type 1 diabetics are not able to produce insulin, and therefore insulin must be provided to the body in the form of injectable products. Type 2 diabetics may be able to produce insulin, but the body is not efficient in utilizing it. Insulin is an essential therapy in both Type 1 and Type 2 diabetes, as well as gestational diabetes and diabetic ketoacidosis.<\/span><\/p>\n

Read more on diabetes here: <\/b>Type 1 vs. Type 2 diabetes: Compare causes, symptoms & treatments<\/b><\/a><\/p>\n

Dosing insulin to maintain adequate control of blood glucose levels is a delicate balance. For some, it may require multiple doses per day or more than one type of insulin. Type 2 diabetics are often dependent on more than one antidiabetic agent to control their blood sugar, including oral medications. Healthcare providers often have to make frequent adjustments and monitor blood sugar levels closely. Adjustments may be needed in the type of insulin used based on blood sugar control. Insurance coverage and formularies often play an important role in determining what insulin a patient can be compliant with long-term due to cost-related factors. Insulin therapy can be very expensive, and costs can sometimes dictate insulin choice for an individual. Fortunately, there are alternative insulin options that can be considered in order to achieve hypoglycemia control.\u00a0<\/span><\/p>\n

What can I take in place of NovoLog Flexpen?<\/span><\/h2>\n

There are alternative options to NovoLog Flexpen (insulin aspart). Alternatives can include other types of rapid-acting insulins, or the use of different types of insulin, which may be short-acting or long-acting. While many consider the use of an insulin pen preferable to the use of a vial and syringe to inject insulin, insulin vials are still an option if needed. There is now an inhaled insulin available as well. Factors that should be considered when selecting an alternative should include dosing frequency, dosing compliance by the patient, cost, and insurance formulary coverage.<\/span><\/p>\n

Today, there are more alternative insulin options available than ever before, thanks to the introduction of <\/span>biosimilar insulin products<\/span><\/a> and interchangeable biosimilar insulin products. Biosimilar insulins are very similar to the original insulin. The FDA considers them safe and effective options with differences only in the inactive ingredients of the formulation. If a product is considered an \u201cinterchangeable biosimilar\u201d this means your pharmacist can make a direct substitution between those products. Biosimilar products that have not been proven with studies to be \u201cinterchangeable\u201d require your prescriber\u2019s permission to make a change. These products may provide a more cost-effective alternative for you in insulin therapy.<\/span><\/p>\n

Check out this related article: <\/b>How much is Novolog Flexpen without insurance?<\/b><\/a><\/p>\n

The below list includes some alternative options to NovoLog Flexpens. It is not intended to be a complete list of alternatives. Only your healthcare provider or endocrinology specialist can determine what is appropriate to treat your diabetes effectively.<\/span><\/p>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
Compare NovoLog Flexpen alternatives<\/span><\/th>\n<\/tr>\n<\/thead>\n
Drug name<\/b><\/td>\nUses<\/b><\/td>\nDosage<\/b><\/td>\nSavings options<\/b><\/td>\n<\/tr>\n
NovoLog Flexpen<\/span><\/a> (insulin aspart)<\/span><\/td>\nGlycemic control in children and adults with diabetes mellitus<\/span><\/td>\n0.4 to 1 unit\/ kg\/ day in divided doses administered 5 to 10 minutes prior to meals<\/span><\/td>\nNovoLog Flexpen coupons<\/span><\/a><\/td>\n<\/tr>\n
Humalog KwikPen <\/span><\/a>(insulin lispro)<\/span><\/td>\nGlycemic control in children and adults with diabetes mellitus<\/span><\/td>\n0.4 to 1 unit\/ kg\/ day in divided doses administered 5 to 10 minutes prior to meals<\/span><\/td>\nHumalog KwikPen coupons<\/span><\/a><\/td>\n<\/tr>\n
Apidra Solostar<\/span><\/a> (insulin glulisine)<\/span><\/td>\nGlycemic control in children and adults with diabetes mellitus<\/span><\/td>\n0.4 to 1 unit\/ kg\/ day in divided doses administered 15 minutes before or within 20 minutes of start of meal<\/span><\/td>\nApidra Solostar coupons<\/span><\/a><\/td>\n<\/tr>\n
Fiasp Flextouch<\/span><\/a> (insulin aspart)<\/span><\/td>\nGlycemic control in children and adults with diabetes mellitus<\/span><\/td>\n0.4 to 1 unit\/ kg\/ day in divided doses administered 15 minutes before or within 20 minutes of start of meal<\/span><\/td>\nFiasp Flextouch coupons<\/span><\/a><\/td>\n<\/tr>\n
Admelog Solostar <\/span><\/a>(insulin lispro)<\/span><\/td>\nGlycemic control in children and adults with diabetes mellitus<\/span><\/td>\n0.4 to 1 unit\/ kg\/ day in divided doses administered 15 minutes before or immediately after meal<\/span><\/td>\nAdmelog coupons<\/span><\/a><\/td>\n<\/tr>\n
Afrezza<\/span><\/a> (inhaled insulin)<\/span><\/td>\nGlycemic control in adults with diabetes mellitus<\/span><\/td>\n4 units inhaled at each meal (in combination with basal insulin) adjusted to glycemic goal<\/span><\/td>\nAfrezza coupons<\/span><\/a><\/td>\n<\/tr>\n
Novolog Mix FlexPen <\/span><\/a>(insulin aspart\/ insulin aspart protamine systemic)<\/span><\/td>\nGlycemic control in adults with diabetes mellitus<\/span><\/td>\n0.4 to 1 unit\/ kg\/ day in two divided doses administered as \u2154 the daily dose before breakfast and \u2153 the daily dose before evening meal<\/span><\/td>\nNovolog Mix coupons<\/span><\/a><\/td>\n<\/tr>\n
Novolin R<\/span><\/a> (insulin regular)<\/span><\/td>\nGlycemic control in children and adults with diabetes mellitus<\/span><\/td>\n0.4 to 1 unit\/ kg\/ day in divided doses administered 30 minutes prior to meals<\/span><\/td>\nNovolin R coupons<\/span><\/a><\/td>\n<\/tr>\n
Lantus Solostar<\/span><\/a> (insulin glargine)<\/span><\/td>\nGlycemic control in children and adults with diabetes mellitus<\/span><\/td>\n0.4 to 1 unit\/ kg\/ day once daily<\/span><\/td>\nLantus Solostar coupons<\/span><\/a><\/td>\n<\/tr>\n
Toujeo Max Solostar<\/span><\/a> (insulin glargine)<\/span><\/td>\nGlycemic control in children and adults with diabetes mellitus<\/span><\/td>\n0.4 to 1 unit\/ kg\/ day once daily<\/span><\/td>\nToujeo Max Solostar coupons<\/span><\/a><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

Other alternatives to Novolog FlexPen<\/span><\/h3>\n